These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1036 related items for PubMed ID: 19243311

  • 1. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 2. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD.
    Prostaglandins Leukot Essent Fatty Acids; 2010 Apr; 82(4-6):265-71. PubMed ID: 20189787
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 6. Non-alcoholic fatty liver disease.
    Smith BW, Adams LA.
    Crit Rev Clin Lab Sci; 2011 Jul; 48(3):97-113. PubMed ID: 21875310
    [Abstract] [Full Text] [Related]

  • 7. [Pediatric non-alcoholic fatty liver disease: recent advances and challenges].
    Poggiogalle E, Olivero G, Anania C, Ferraro F, Pacifico L.
    Minerva Pediatr; 2010 Dec; 62(6):569-84. PubMed ID: 21042270
    [Abstract] [Full Text] [Related]

  • 8. [Non-alcoholic fatty liver].
    Tagle Arrospide M.
    Rev Gastroenterol Peru; 2003 Dec; 23(1):49-57. PubMed ID: 12768215
    [Abstract] [Full Text] [Related]

  • 9. The clinical aspects of non-alcoholic fatty liver disease.
    Björnsson E.
    Minerva Gastroenterol Dietol; 2008 Mar; 54(1):7-18. PubMed ID: 18299664
    [Abstract] [Full Text] [Related]

  • 10. ASH and NASH.
    Scaglioni F, Ciccia S, Marino M, Bedogni G, Bellentani S.
    Dig Dis; 2011 Mar; 29(2):202-10. PubMed ID: 21734385
    [Abstract] [Full Text] [Related]

  • 11. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
    Preiss D, Sattar N.
    Clin Sci (Lond); 2008 Sep; 115(5):141-50. PubMed ID: 18662168
    [Abstract] [Full Text] [Related]

  • 12. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
    Cortez-Pinto H, Camilo ME.
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1089-104. PubMed ID: 15561640
    [Abstract] [Full Text] [Related]

  • 13. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R, Cusi K.
    Ann Med; 2009 Dec; 41(4):265-78. PubMed ID: 19353360
    [Abstract] [Full Text] [Related]

  • 14. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A.
    Eur Rev Med Pharmacol Sci; 2005 Dec; 9(5):273-7. PubMed ID: 16231589
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP.
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [Abstract] [Full Text] [Related]

  • 16. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.
    Wieckowska A, McCullough AJ, Feldstein AE.
    Hepatology; 2007 Aug; 46(2):582-9. PubMed ID: 17661414
    [Abstract] [Full Text] [Related]

  • 17. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L, Forgione A, Gasbarrini G, Grieco A.
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [Abstract] [Full Text] [Related]

  • 18. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA, Kunde SS, Lazenby AJ, Clements RH.
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [Abstract] [Full Text] [Related]

  • 19. A fresh look at NASH pathogenesis. Part 1: the metabolic movers.
    Larter CZ, Chitturi S, Heydet D, Farrell GC.
    J Gastroenterol Hepatol; 2010 Apr; 25(4):672-90. PubMed ID: 20492324
    [Abstract] [Full Text] [Related]

  • 20. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
    Tessari P, Coracina A, Cosma A, Tiengo A.
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.